New Open Science partnership will pave way for better treatments, faster | Montreal Neurological Institute and Hospital - McGill University

Amyluv's bookmarks 2017-12-07


"A new partnership between the Structural Genomics Consortium (SGC) and the Montreal Neurological Institute and Hospital (The Neuro) will use a unique open science framework to help scientists discover new targets for drug development for neurological diseases.

The partnership, called NeuroSGC, will initially focus on Parkinson’s disease and amyotrophic lateral sclerosis (ALS), two of the most common neurodegenerative diseases."


From feeds:

Open Access Tracking Project (OATP) » Amyluv's bookmarks

Tags: oa.neuro oa.scholcomm oa.reproducibility oa.pharma oa.collaboration oa.infrastructure

Date tagged:

12/07/2017, 16:19

Date published:

12/07/2017, 11:19